Fibrocytes in health and disease

Experimental Hematology

Volumn 38, Issue 7, 2010, Pages 548-556

  Herzog, Erica L ^a   Bucala, Richard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; CD34 ANTIGEN; CD45 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; GROWTH FACTOR; SEMAPHORIN; VIMENTIN;

ASTHMA; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL TRANSPORT; CHRONIC INFLAMMATION; CONNECTIVE TISSUE CELL; CYTOLOGY; FIBROGENESIS; FIBROSIS; HEART DISEASE; HUMAN; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG FIBROSIS; MESENCHYMAL STEM CELL; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SKIN DISEASE; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; DISEASE; FIBROSIS; HUMANS; MESENCHYMAL STEM CELLS;

ANIMALIA;

EID: 77953544771     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.03.004     Document Type: Review

References (69)

1. Wilson M.S., Wynn T.A. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2009, 2:103-121.
2. Lee C.G., Homer R.J., Cohn L., et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 2002, 277:35466-35474.
3. Noble P.W., Homer R.J. Idiopathic pulmonary fibrosis: new insights into pathogenesis. Clin Chest Med 2004, 25:749-758. vii.
4. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006, 69:213-217.
5. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006, 47:C7-C12.
6. Tuan T.L., Nichter L.S. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998, 4:19-24.
7. Orimo A., Gupta P.B., Sgroi D.C., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
8. Kim K.K., Wei Y., Szekeres C., et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009, 119:213-224.
9. Pereira R.F., Halford K.W., O'Hara M.D., et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995, 92:4857-4861.
10. Cohnheim J. Ueber Entzundung und Eiterung (About inflammation and suppuration). Path Anat Physiol Klin Med 1867, 40:1-79.
11. Fischer A.C. Transformation outside of organism of mononuclears into fibroblasts. Compt Rend Soc Biol 1925, 92:109-112.
12. Maximow A. Cultures of blood leucocytes. From lymphocyte and monocyte to connective tissue. Arch Exp Zellforsch 1928, 5:169-268.
13. Bucala R., Spiegel L.A., Chesney J., Hogan M., Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994, 1:71-81.
14. Medbury H. Role of fibrocytes in atherogenesis. Fibrocytes: new insights into tissue repair and systemic fibroses 2007, 175-194. World Scientific Publishing Co. Pte. Ltd, Singapore. R. Bucala (Ed.).
15. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166:7556-7562.
16. Mehrad B., Burdick M.D., Zisman D.A., Keane M.P., Belperio J.A., Strieter R.M. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007, 353:104-108.
17. Moeller A., Gilpin S.E., Ask K., et al. Circulating fibrocytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179:588-594.
18. Pilling D., Fan T., Huang D., Kaul B., Gomer R.H. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009, 4:e7475.
19. Yang L., Scott P.G., Dodd C., et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 2005, 13:398-404.
20. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front Biosci 2008, 13:453-461.
21. Schmidt M., Sun G., Stacey M.A., Mori L., Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003, 171:380-389.
22. Chesney J., Metz C., Stavitsky A.B., Bacher M., Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998, 160:419-425.
23. Hartlapp I., Abe R., Saeed R.W., et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001, 15:2215-2224.
24. Chesney J., Bacher M., Bender A., Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 1997, 94:6307-6312.
25. Pilling D., Buckley C.D., Salmon M., Gomer R.H. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003, 171:5537-5546.
26. Shao D.D., Suresh R., Vakil V., Gomer R.H., Pilling D. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 2008, 83:1323-1333.
27. Niedermeier M., Reich B., Rodriguez Gomez M., et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci U S A 2009, 106:17892-17897.
28. Mehrad B., Burdick M.D., Strieter R.M. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 2009, 41:1708-1718.
29. Sakai N., Wada T., Matsushima K., et al. The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens 2008, 26:780-790.
30. Phillips R.J., Burdick M.D., Hong K., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004, 114:438-446.
31. Quan T.E., Cowper S., Wu S.P., Bockenstedt L.K., Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004, 36:598-606.
32. Gomperts B.N., Strieter R.M. Fibrocytes in lung disease. J Leukoc Biol 2007, 82:449-456.
33. Lin S.L., Kisseleva T., Brenner D.A., Duffield J.S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008, 173:1617-1627.
34. Kisseleva T., Uchinami H., Feirt N., et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006, 45:429-438.
35. Hashimoto N., Jin H., Liu T., Chensue S.W., Phan S.H. Bone marrow derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004, 113:243-252.
36. Moore B.B., Murray L., Das A., Wilke C.A., Herrygers A.B., Toews G.B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006, 35:175-181.
37. Sakai N., Wada T., Yokoyama H., et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 2006, 103:14098-14103.
38. Wang C.H., Huang C.D., Lin H.C., et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 2008, 178:583-591.
39. Nihlberg K., Larsen K., Hultgårdh-Nilsson A., Malmström A., Bjermer L., Westergren-Thorsson G. Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane?. Respir Res 2006, 7:50.
40. Saunders R., Siddiqui S., Kaur D., et al. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J Allergy Clin Immunol 2009, 123:376-384.
41. Ortiz L.A., Gambelli F., McBride C., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003, 100:8407-8411.
42. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002, 165:277-304. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.
43. Andersson-Sjöland A., de Alba C.G., Nihlberg K., et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008, 40:2129-2140.
44. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007, 170:1807-1816.
45. Ishida Y., Kimura A., Takayasu T., Eisenmenger W., Kondo T. Detection of fibrocytes in human skin wounds and its application for wound age determination. Int J Legal Med 2009, 123:299-304.
46. Aiba S., Tagami H. Phorbol 12-myristate 13-acetate can transform monocyte-derived dendritic cells to different cell types similar to those found in dermatofibroma. A possible in vitro model of the histogenesis of dermatofibroma. J Cutan Pathol 1998, 25:65-71.
47. Aiba S., Tagami H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutan Pathol 1997, 24:65-69.
48. Yang L., Scott P.G., Giuffre J., Shankowsky H.A., Ghahary A., Tredget E.E. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002, 82:1183-1192.
49. Wang J.F., Jiao H., Stewart T.L., Shankowsky H.A., Scott P.G., Tredget E.E. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 2007, 15:113-121.
50. Yau F.M., Scott P.G., Ghahary A., et al. Peripheral blood fibrocytes and scar formation. UAHSJ 2005, 2:4-7.
51. Russo R., Medbury H., Guiffre A., Englert H., Manolios N. Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clin Rheumatol 2007, 26:1136-1141.
52. Cowper S.E., Bucala R., LeBoit P.E. Case 35-2004: nephrogenic fibrosing dermopathy. N Engl J Med 2005, 352:1723-1724. Author reply 1723-1724.
53. Cowper S.E., Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 2003, 25:358.
54. Vakil V., Sung J.J., Piecychna M., et al. Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation. J Magn Reson Imaging 2009, 30:1284-1288.
55. Haudek S.B., Xia Y., Huebener P., et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A 2006, 103:18284-18289.
56. Roberts R., Sigwart U. Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. Circulation 2005, 112:293-296.
57. Barth P.J., Koster H., Moosdorf R. CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol Res Pract 2005, 201:301-304.
58. Guyot C., Lepreux S., Combe C., et al. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006, 38:135-151.
59. Zeisberg M., Yang C., Martino M., et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007, 282:23337-23347.
60. Forbes S.J., Russo F.P., Rey V., et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004, 126:955-9639.
61. Schoolwerth A.C., Engelgau M.M., Hostetter T.H., et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis 2006, 3:A57.
62. Broekema M., Harmsen M.C., van Luyn M.J., et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J Am Soc Nephrol 2007, 18:165-175.
63. Roufosse C., Bou-Gharios G., Prodromidi E., et al. Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. J Am Soc Nephrol 2006, 17:775-782.
64. Herzog E.L., Chai L., Krause D.S. Plasticity of marrow-derived stem cells. Blood 2003, 102:3483-3493.
65. Okon K., Szumera A., Kuzniewski M. Are CD34+ cells found in renal interstitial fibrosis?. Am J Nephrol 2003, 23:409-414.
66. Xu J., Gonzalez E.T., Iyer S.S., et al. Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow-derived cells can alter the outcome of lung injury in aged mice. J Gerontol A Biol Sci Med Sci 2009, 64:731-739.
67. Akdis C.A., Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009, 123:735-746. quiz 747-748.
68. Kotsianidis I., Nakou E., Bouchilou I., et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179:1121-1130.
69. Mittal S.K., Sharma R.K., Gupta A., Naik S. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. Transplantation 2009, 88:435-441.